| mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.31 |
2e-12 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
6e-07 |
| mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
-0.22 |
3e-06 |
| mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
1e-05 |
| mRNA |
ATRA |
FIMM |
pan-cancer |
AAC |
0.79 |
2e-05 |
| mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
-0.2 |
2e-05 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-05 |
| mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
3e-05 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
4e-05 |
| mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
5e-05 |